Tobias Samuel, Grant Cameron J, Laing Richard, Lysyshyn Mark, Buxton Jane A, Tupper Kenneth W, Wood Evan, Ti Lianping
British Columbia Centre on Substance Use, Vancouver, British Columbia, Canada.
School of Population and Public Health, The University of British Columbia, Vancouver, British Columbia, Canada.
BMJ Public Health. 2023 Oct 12;1(1):e000197. doi: 10.1136/bmjph-2023-000197. eCollection 2023 Nov.
Increases in fatal overdoses were observed coinciding with the COVID-19 pandemic across the USA and Canada. Hypothesised explanations include pandemic-attributable healthcare service disruption, social isolation and illicit drug market disruption. Using data from a community drug checking service, this study sought to evaluate how COVID-19 pandemic measures affected the variability in fentanyl concentrations within the local illicit drug market.
Using a validated quantification model for fentanyl, Fourier-transform infrared spectra from fentanyl-positive drug checking samples in Vancouver, Canada were analysed to determine fentanyl concentration. An interrupted time-series analysis using an ordinary least squares model with autoregressive adjusted SEs was conducted to measure how the variance in monthly fentanyl concentrations changed following the declaration of the COVID-19 public health emergency in March 2020.
Over the study period, 4713 fentanyl-positive samples were available for analysis. Monthly variance of fentanyl concentrations ranged from 7.9% in December 2017 to 159.2% in September 2020. An interrupted time-series analysis of variance in fentanyl concentrations increased significantly following the declaration of the COVID-19 public health emergency, with an immediate level change of 26.1 (95% CI 7.2 to 45.0, p=0.011) and a slope change of 15.8 (95% CI 10.2 to 21.4, p<0.001).
Though community drug checking samples may not be generalisable to the wider illicit drug market, our study found that variance in fentanyl concentrations increased significantly following the declaration of the COVID-19 public health emergency. While it remains unclear whether the observed increase in the variability of fentanyl concentration in illicit opioids was a direct result of COVID-19 and related measures, the volatility of fentanyl concentrations is likely to have posed significant risk to people who used drugs in this setting.
在美国和加拿大,致命药物过量事件的增加与新冠疫情同时出现。推测的解释包括疫情导致的医疗服务中断、社会隔离以及非法毒品市场混乱。本研究利用社区药物检测服务的数据,旨在评估新冠疫情措施如何影响当地非法毒品市场中芬太尼浓度的变异性。
使用经过验证的芬太尼定量模型,对加拿大温哥华芬太尼阳性药物检测样本的傅里叶变换红外光谱进行分析,以确定芬太尼浓度。采用带有自回归调整标准误的普通最小二乘法模型进行中断时间序列分析,以衡量2020年3月宣布新冠公共卫生紧急情况后每月芬太尼浓度的方差如何变化。
在研究期间,有4713份芬太尼阳性样本可供分析。芬太尼浓度的月度方差范围从2017年12月的7.9%到2020年9月的159.2%。对芬太尼浓度方差的中断时间序列分析显示,在宣布新冠公共卫生紧急情况后显著增加,即时水平变化为26.1(95%置信区间7.2至45.0,p=0.011),斜率变化为15.8(95%置信区间10.2至21.4,p<0.001)。
尽管社区药物检测样本可能无法推广到更广泛的非法毒品市场,但我们的研究发现,在宣布新冠公共卫生紧急情况后,芬太尼浓度的方差显著增加。虽然尚不清楚非法阿片类药物中芬太尼浓度变异性的观察到的增加是否是新冠疫情及相关措施的直接结果,但芬太尼浓度的波动可能给在此环境下使用毒品的人带来了重大风险。